Consistent with our genetic studies, the human AML1-ETO-fusion-driven cell line Kasumi-1 also demonstrated increased sensitivity to GSK343 at similar IC50 to the murine AML tumors (Fig. S3 a), with marked reduction in liquid culture expansion compared with vehicle control (Fig. 2 d). Here, RUNX1 is linked to acute myeloid leukemia.